This was followed by retail investors and qualified institutional buyers (QIBs), who oversubscribed their respective categories by 1.36 times and 1.11 times, respectively.
How to check Amir Chand IPO allotment status online on BSE – Step-by-Step Guide
Step 1: Visit the BSE website
Open your web browser and go to: https://www.bseindia.com
Step 2: Navigate to the Application Status Check
Click on the ‘Investors’ tab in the top menu bar. From the dropdown menu, select ‘IPO’ and then ‘Application Status Check’.
Alternatively, you can go directly to: https://www.bseindia.com/investors/appli_check.aspx
Step 3: Enter the required information
In the ‘Issue Type’ field, select ‘Equity’.
In the ‘Company Name’ field, type ‘Amir Chand Jagdish Kumar’.
Enter either your PAN number or your application number.
Step 4: Click ‘Search’
Once you have entered the required details, click the ‘Search’ button.
Step 5: View the allotment status
The website will display your allotment status, indicating whether or not you have been allotted shares.
If allotted, you will receive the credit of equivalent shares in your Demat account.
Check Amir Chand IPO allotment status online on registrar’s website – Direct link
Investors can also check the allotment status of the Amir Chand IPO by visiting the official website of Kfin Technologies:
Check Amir Chand IPO allotment status online on NSE
Additionally, investors can check the allotment status on the NSE website by visiting:
Amir Chand IPO GMP
Ahead of the allotment, the unlisted shares of Amir Chand were commanding a decent premium in the grey market on Monday. Sources tracking grey market activity revealed that the company’s unlisted shares were trading at around ₹215 per share, reflecting a grey market premium (GMP) of ₹3 per share, or 1.42 per cent over the upper end of the issue price.
Amir Chand IPO listing forecast
Shares of Amir Chand are scheduled to list on the BSE and NSE on Thursday, April 2, 2026. The current grey market trends indicate a favourable listing for the company’s shares. However, given that grey markets remain unregulated, analysts advise caution and suggest that GMP should not be taken as the sole indicator of listing performance.